ReviewNature reviews. Molecular cell biology2026
Atomic, structural and molecular insights into GPCR ligand binding and signalling.
Review in Nature reviews. Molecular cell biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
G-protein-coupled receptors (GPCRs) are the largest group of human membrane proteins, comprising over 800 members, and represent the most common target of therapeutics. GPCRs orchestrate context-dependent functions and have diverse physiological roles. Recent advances have enabled the exploration of GPCR structure, function and regulation, leading to a deeper understanding of their signalling complexity. In this Review, we synthesize these advances at different scales of increasing complexity and discuss atomic-level, structural-level and molecular-level insights into GPCR signalling. Specifically, we highlight the context-dependent mechanisms by which GPCRs translate extracellular cues into intracellular signals through ligand recognition, ligand-induced conformational changes, engagement with different adaptors and interactions with various molecular pathways, as well as how these processes are modulated during disease, and the new therapeutic opportunities they present. Through inter-disciplinary efforts aimed at elucidating GPCR multiscale signalling, we are approaching a holistic understanding that will inform the rational development of specific, effective and safer medicines.
Identifiers
42870060What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.